Respiratory Conditions Management Flashcards
Chronic Brochitis - Management (3/6/0)
conservative 1) smoking cessation 2) pulmonary rehabilitation (inc. exercise, education, breathing techniques) 3) vaccinations (annual influenza, pneumococcal) medical 1) LAMA 2) SAβA (as required) 3) INH corticosteroid (severe) 4) long term domiciliary oxygen therapy (severe, non-smokers) 5) antimucolytic 6) diuretic (oedema)
Emphysema - Management (3/5/0)
conservative 1) smoking cessation 2) pulmonary rehabilitation (exercise, education, breathing techniques) 3) vaccinations (annual influenza, pneumococcal) medical 1) LAMA (+ LAβA in persistent dyspnoea) 2) SAβA (as required) 3) INH corticosteroid (severe) 4) long term domiciliary oxygen therapy (severe, non-smoker) 5) alpha-1-antitrypsin replacement (deficiency)
Asthma - Management (3/6/0)
conservative 1) avoid allergen 2) inhaler technique 3) vaccinations (influenza) medical 1) SAβA (as required) 2) + LAβA 3) + INH corticosteroid (beclometasone) (increase dose as required) 4) PO corticosteroid (prednisolone) (severe) 5) montelukast (consider if severe) 6) theophylline (consider if severe)
Asthma - Management (Attack) (5)
1) NEB SAβA 2) PO corticosteroid (prednisolone) 3) oxygen therapy (severe) 4) anti-ACh (ipatropium) (severe) 5) magnesium (severe)
Small Cell Lung Carcinoma - Management (0/3/1)
medical 1) chemotherapy 2) radiotherapy 3) prophylactic cranial irradiation surgery 1) surgical excision (e.g. lobectomy) (rare due to late presentation)
Non-Small Cell Lung Carcinoma - Management (0/2/1)
medical 1) chemotherapy 2) radiotherapy surgery 1) surgical excision (e.g. lobectomy)
Pulmonary Embolism - Management (0/5/2)
medical 1) IV fluids 2) adrenaline 3) oxygen (high flow, 60-100%) 4) anticoagulant (LMW heparin + warfarin) 5) thrombolysis (IV alteplase) surgery 1) pulmonary thrombectomy (thrombolysis contraindicated) 2) vena caval filter (thrombolysis contraindicated) (can be long term)
Community Acquired Pneumonia - Management (4/4/2)
conservative 1) smoking cessation 2) rest 3) fluids (IV if dehydrated or shock) 4) vaccination (influenzae, pneumococcal) medical 1) hospital guideline empirical antibiotics (e.g. amoxicillin, clarithromycin) 2) specific antibiotics (severe) 3) oxygen (aim for SaO2>94% or SaO2>88% in COPD) 4) analgesia (pleuritic pain) surgery 1) thoracentesis (pleural effusion) 2) surgical drainage (lung abscess)
Hospital Acquired Pneumonia - Management (4/4/2)
conservative 1) smoking cessation 2) rest 3) fluids (IV if dehydrated or shock) 4) vaccinations (influenzae, pneumococcal) medical 1) hospital guideline empirical antibiotics (e.g. amoxicillin, clarithromycin) (before culture results) 2) specific antibiotics (after culture results) 3) oxygen (aim for SaO2>94%, SaO2>88% in COPD) 4) analgesia (pleuritic pain) surgery 1) thoracentesis (pleural effusion) 2) surgical drainage (lung abscess)
Immunocompromised Pneumonia - Management (4/4/2)
conservative 1) smoking cessation 2) rest 3) fluids (IV if dehydrated or shock) 4) vaccinations (influenzae, pneumococcal) medical 1) hospital guideline empirical antibiotics (amoxicillin, clarithromycin) (before culture results) 2) specific antibiotics (after culture results) 3) oxygen (aim for SaO2>94%, SaO2>88% in COPD) 4) analgesia (pleuritic pain) surgery 1) thoracocentesis (pleural effusion) 2) surgical drainage (lung abscess)
Aspiration Pneumonia - Management (4/4/2)
conservative 1) smoking cessation 2) rest 3) fluids (IV if dehydrated or shock) 4) vaccinations (influenzae, pneumococcal) medical 1) hospital guideline empirical antibiotics (e.g. amoxicillin, clarithromycin) (before culture results) 2) specific antibiotics (after culture results) 3) oxygen (aim for SaO2>94%, SaO2>88% in COPD) 4) analgesia (pleuritic pain) surgery 1) thoracentesis (pleural effusion) 2) surgical drainage (lung abscess)
Tuberculosis - Management (5/4/0)
conservative 1) neonatal BCG vaccine 2) notify Public Health England 3) ensure medical compliance 4) contact tracking 5) screening patient contacts medical 1) rifampicin (2 months intensive, 4 months continuation) 2) isoniazid (2 months intensive, 4 months continuation) 3) pyrazinamide (2 months intensive) 4) ethambutol (2 months intensive)
Type I Respiratory Failure - Management (0/4/0)
medical 1) treat underlying cause 2) face mask oxygen (24-60%) 3) assisted ventilation oxygen (>60%) (e.g. CPAP) 4) endotracheal intubation + mechanical ventilation oxygen (unconscious)
Type II Respiratory Failure - Management (0/4/0)
medical 1) treat underlying cause 2) face mask oxygen (24-60%) 3) assisted ventilation oxygen (>60%) (e.g. CPAP) 4) endotracheal intubation + mechanical ventilation oxygen (unconscious)